Triple-negative breast cancer (TNBC), a high-grade breast cancer with poor prognosis, is characterized by the lack of estrogen and progesterone receptors and human epidermal growth factor receptor 2 (HER2) [1, 2]. Here, ERBB2 is linked to triple-negative breast carcinoma.